SCHEMBL28619927

SCHEMBL28619927

NC(=O)c1ccccc1C1=CN=Cc2ccccc2S1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 1/20 0.42
KEAP1 Q14145 1/20 0.39
NFE2L2 Q16236 1/20 0.39
CSNK1A1 P48729 1/20 0.38
TYRO3 Q06418 1/20 0.38
DYRK1B Q9Y463 1/20 0.38
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
TRPA1 O75762 4/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
NUDT1 P36639 1/20 0.35
CHEK1 O14757 1/20 0.34
PARP1 P09874 2/20 0.33
GRM5 P41594 1/20 0.33
METAP2 P50579 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30514077 0.68 BCAT2 (0.74) BCAT2KEAP1NFE2L2CSNK1A1TYRO3
SCHEMBL210767 0.68 BCAT2 (0.74) BCAT2KEAP1NFE2L2CSNK1A1TYRO3
SCHEMBL5637470 0.68 TRPA1 (0.46) TRPA1GPR84
SCHEMBL28619928 0.68 BCAT2 (0.41) BCAT2KEAP1NFE2L2CSNK1A1TYRO3
Hydrochloric Acid SCHEMBL16463881 0.66 BCAT2 (0.71) BCAT2KEAP1NFE2L2CSNK1A1TYRO3
SCHEMBL31012518 0.66 BCAT2 (0.71) BCAT2KEAP1NFE2L2CSNK1A1TYRO3
SCHEMBL1110181 0.66 BCAT2 (0.71) BCAT2KEAP1NFE2L2CSNK1A1TYRO3
SCHEMBL29116644 0.64 TRPA1 (0.46) TRPA1GPR84
SCHEMBL11569294 0.63 TRPA1 (0.44) TRPA1
SCHEMBL5878337 0.63 BCAT2 (0.87) BCAT2KEAP1NFE2L2CSNK1A1TYRO3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107889487-B Bicyclic tetrahydrothiazepine derivatives for the treatment of tumor and/or infectious diseases 阿派隆生物制剂股份公司 2021-09-03 CN disclosed